LeMaitre Vascular, Inc.
LMAT
$79.47
-$0.12-0.15%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.85% | 13.27% | 13.53% | 13.07% | 14.11% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.85% | 13.27% | 13.53% | 13.07% | 14.11% |
| Cost of Revenue | 1.86% | 4.06% | 6.96% | 7.67% | 9.14% |
| Gross Profit | 16.31% | 17.45% | 16.53% | 15.57% | 16.48% |
| SG&A Expenses | 8.54% | 15.12% | 18.43% | 21.36% | 20.70% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.58% | 8.53% | 11.27% | 12.43% | 12.43% |
| Operating Income | 32.40% | 28.77% | 20.77% | 15.17% | 20.00% |
| Income Before Tax | 39.18% | 38.23% | 32.19% | 27.21% | 23.14% |
| Income Tax Expenses | 38.44% | 38.43% | 35.94% | 21.18% | 17.05% |
| Earnings from Continuing Operations | 39.39% | 38.17% | 31.10% | 29.08% | 25.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 39.39% | 38.17% | 31.10% | 29.08% | 25.04% |
| EBIT | 32.40% | 28.77% | 20.77% | 15.17% | 20.00% |
| EBITDA | 28.10% | 25.43% | 18.86% | 13.71% | 17.32% |
| EPS Basic | 38.09% | 36.98% | 30.00% | 27.97% | 23.97% |
| Normalized Basic EPS | 30.91% | 29.77% | 23.64% | 17.36% | 22.09% |
| EPS Diluted | 38.88% | 37.63% | 30.12% | 27.13% | 23.56% |
| Normalized Diluted EPS | 27.59% | 28.41% | 21.94% | 15.13% | 21.47% |
| Average Basic Shares Outstanding | 0.95% | 0.86% | 0.83% | 0.86% | 0.90% |
| Average Diluted Shares Outstanding | 3.71% | 2.10% | 2.33% | 2.75% | 1.43% |
| Dividend Per Share | 25.00% | 25.00% | 25.00% | 22.58% | 20.00% |
| Payout Ratio | -0.09% | -0.09% | -0.04% | -0.04% | -0.03% |